PT100155A - Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas - Google Patents

Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas

Info

Publication number
PT100155A
PT100155A PT100155A PT10015592A PT100155A PT 100155 A PT100155 A PT 100155A PT 100155 A PT100155 A PT 100155A PT 10015592 A PT10015592 A PT 10015592A PT 100155 A PT100155 A PT 100155A
Authority
PT
Portugal
Prior art keywords
camptotecin
medication
pharmaceutical compositions
non small
analog compounds
Prior art date
Application number
PT100155A
Other languages
English (en)
Other versions
PT100155B (pt
Inventor
Randall Keith Johnson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PT100155A publication Critical patent/PT100155A/pt
Publication of PT100155B publication Critical patent/PT100155B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
PT100155A 1991-02-21 1992-02-21 Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas PT100155B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65893791A 1991-02-21 1991-02-21

Publications (2)

Publication Number Publication Date
PT100155A true PT100155A (pt) 1993-05-31
PT100155B PT100155B (pt) 1999-09-30

Family

ID=24643331

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100155A PT100155B (pt) 1991-02-21 1992-02-21 Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas

Country Status (14)

Country Link
US (1) US5756512A (pt)
EP (1) EP0572549B1 (pt)
JP (1) JP2738979B2 (pt)
KR (1) KR930702984A (pt)
AT (1) ATE227991T1 (pt)
AU (2) AU1531992A (pt)
CA (1) CA2103707C (pt)
DE (1) DE69232852T2 (pt)
DK (1) DK0572549T3 (pt)
ES (1) ES2187500T3 (pt)
HK (1) HK1012267A1 (pt)
MX (1) MX9200755A (pt)
PT (1) PT100155B (pt)
WO (1) WO1992014471A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7732996A (en) * 1995-11-22 1997-06-11 Research Triangle Institute Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
AU2015240465B2 (en) 2014-04-04 2020-02-27 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells

Also Published As

Publication number Publication date
ES2187500T3 (es) 2003-06-16
US5756512A (en) 1998-05-26
DK0572549T3 (da) 2003-01-06
KR930702984A (ko) 1993-11-29
EP0572549A1 (en) 1993-12-08
AU1531992A (en) 1992-09-15
AU4042795A (en) 1996-02-22
WO1992014471A1 (en) 1992-09-03
JPH06505741A (ja) 1994-06-30
EP0572549B1 (en) 2002-11-20
HK1012267A1 (en) 1999-07-30
JP2738979B2 (ja) 1998-04-08
CA2103707C (en) 2003-12-09
DE69232852T2 (de) 2003-09-04
EP0572549A4 (pt) 1994-01-12
DE69232852D1 (de) 2003-01-02
CA2103707A1 (en) 1992-08-22
ATE227991T1 (de) 2002-12-15
PT100155B (pt) 1999-09-30
AU699436B2 (en) 1998-12-03
MX9200755A (es) 1992-08-01

Similar Documents

Publication Publication Date Title
ES2080837T5 (es) Uso de acido hialuronico en combinacion con acido ascorbico, agentes antitumorales y/o faine para el tratamiento del cancer.
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
PT101061A (pt) Composicoes farmaceuticas contendo anagolos da camptotecina e um composto de coordenacao de platina e seu uso na inibicao do crescimento de celulas tumorais
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
DE3883035T2 (de) Saponinkomplexe mit Phospholipiden und sie enthaltende pharmazeutische und kosmetische Zusammensetzungen.
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ATE231863T1 (de) 6-amino-purinderivate mit pde-iv inhibierender wirkung
SE8504967L (sv) Farmaceutisk komposition och forfarande for behandling av kroppen
ATE177640T1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
PT100155A (pt) Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
FI801228A (fi) 6-substituerade 11-alkylen-morfantridiner foerfaranden foer deras framstaellning och terapeutiska medel innehaollande dessa
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DE3373978D1 (en) Composition for the care or treatment of the human skin
ES2031462T3 (es) Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima.
EG17992A (en) Preparation of a medicament for arthritis and theumatism
ZA837972B (en) Method of analgesic treatment and pharmaceutical compositions
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases
PT98538A (pt) Processo de preparacao de factor de crescimento humano epidermico (hegf) dos seus congeneres e de composicoes farmaceuticas que os contem
KR880002521A (ko) 약제 제형
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930122

FG3A Patent granted, date of granting

Effective date: 19990622

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20091222